LEGN
Legend Biotech·NASDAQ
--
--(--)
--
--(--)
LEGN fundamentals
Legend Biotech (LEGN) released its earnings on Mar 10, 2026: revenue was 306.30M (YoY +64.22%), missed estimates; EPS was -0.08 (YoY -214.29%), missed estimates.
Revenue / YoY
306.30M
+64.22%
EPS / YoY
-0.08
-214.29%
Report date
Mar 10, 2026
LEGN Earnings Call Summary for Q4,2025
- CARVYKTI Growth Accelerates: Q4 2025 sales $555M (+66% YoY), with 50.4-month PFS in triple-class exposed patients.
- Profitability Milestone: CARVYKTI franchise profitable in 2025; company-wide profitability expected in 2026.
- Community Adoption Surge: 1/3 U.S. treatment centers are regional hospitals, 50% doses administered outpatient.
- Pipeline Momentum: First in vivo CAR-T data expected in 2026; 1-2 U.S. IND filings planned.
- Financial Strength: $949M cash, 61% gross margin, operating loss narrowed 75% YoY.
EPS
Actual | -0.63 | -0.25 | -0.22 | -0.3 | -0.33 | -0.43 | -0.3 | -0.13 | -0.35 | -0.37 | -0.32 | -0.34 | -0.57 | -0.17 | -0.4 | -0.16 | -0.05 | -0.34 | 0.07 | -0.27 | -0.34 | -0.11 | -0.08 |
Forecast | -0.26 | -0.3067 | -0.2833 | -0.35 | -0.335 | -0.4156 | -0.3418 | -0.3583 | -0.3102 | -0.3733 | -0.3831 | -0.4175 | -0.3609 | -0.3101 | -0.3556 | -0.1935 | -0.2874 | -0.3297 | -0.2474 | -0.2104 | -0.1135 | -0.0727 | 0.0005 |
Surprise | -142.31% | +18.49% | +22.34% | +14.29% | +1.49% | -3.46% | +12.23% | +63.72% | -12.83% | +0.88% | +16.47% | +18.56% | -57.94% | +45.18% | -12.49% | +17.31% | +82.60% | -3.12% | +128.29% | -28.33% | -199.56% | -51.31% | -16100.00% |
Revenue
Actual | 11.60M | 11.75M | 40.78M | 13.68M | 20.23M | 16.88M | 38.99M | 40.83M | 15.20M | 27.50M | 27.52M | 36.34M | 73.33M | 96.01M | 79.46M | 93.99M | 186.52M | 160.21M | 186.52M | 195.05M | 255.06M | 272.33M | 306.30M |
Forecast | 13.00M | 13.00M | 13.00M | 6.50M | 9.13M | 7.83M | 14.27M | 25.00M | 33.62M | 32.34M | 36.06M | 42.18M | 56.64M | 97.25M | 94.08M | 143.24M | 125.25M | 143.91M | 178.88M | 193.65M | 228.96M | 274.42M | 307.76M |
Surprise | -10.77% | -9.64% | +213.72% | +110.49% | +121.53% | +115.51% | +173.25% | +63.31% | -54.79% | -14.97% | -23.69% | -13.85% | +29.48% | -1.28% | -15.53% | -34.38% | +48.92% | +11.32% | +4.27% | +0.73% | +11.40% | -0.76% | -0.47% |
Earnings Call
You can ask Aime
What is Legend Biotech's latest dividend and current dividend yield?What does Legend Biotech do and what are its main business segments?What factors drove the changes in Legend Biotech's revenue and profit?What were the key takeaways from Legend Biotech's earnings call?What is the market's earnings forecast for Legend Biotech next quarter?What is Legend Biotech's gross profit margin?What is the revenue and EPS growth rate for Legend Biotech year over year?What were the key takeaways from Legend Biotech’s earnings call?
